OSCROscar Health, Inc.
Hospital & Medical Service Plans
- Revenue
- $29M
- 39% YoY
- Operating margin
- -1386.2%
- 598% YoY
- EBITDA
- −$367M
- 511% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- —
- −$3.6B net debt
- AI in 10-K
- —
Red flags 1 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear—Cash flow under 80% of net income
- Dilutive SBCFired307% of revenueOver 10% of revenue
- Payouts exceed cash flowClear0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear—Over 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $5M | $65M | $21M | $21M | $29M | 39% |
| Operating income | −$544M | −$590M | −$236M | $57M | −$396M | 792% |
| Net income | −$573M | −$606M | −$271M | $25M | −$443M | 1842% |
| Operating cash flow | −$182M | $380M | −$272M | $978M | $1.1B | 12% |
| Capex | $26M | $29M | $26M | $28M | $36M | 30% |
| Stock-based comp | $86M | $112M | $160M | $110M | $88M | 20% |
| Buybacks | $0 | — | — | — | — |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $3M · 6
- Net
- −$3M
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2025 | — | — | 41 | 100 |
| FY2024 | — | — | 39 | 91 |
| FY2023 | — | — | 26 | 124 |
| FY2022 | — | — | 7 | 136 |
| FY2021 | — | — | 23 | 128 |